Human T-cell Leukemia Virus type-1 (HTLV-1) is highly immunogenic and has low variability so tight regulation of its expression is essential for virus maintenance in vivo. HTLV-1 replication is positively regulated by Tax and Rex, and negatively by the p30 and HBZ proteins. Here, we demonstrate that HTLV-1 encodes another negative regulator of virus expression, the p13 protein. Expressed separately, p13 localizes to the mitochondria, but in the presence of Tax, p13 is stabilized, and re-routed to the nuclear speckles. The p13 protein directly binds Tax, decreases Tax binding to the CBP/p300 transcriptional co-activator and, by reducing Tax transcriptional activity, suppresses viral expression. These findings suggest that HTLV-1 has evolved a complex mechanism to control its own replication through regulation of positive and negative viral proteins. Further, these results emphasize the importance of studying the function of the HTLV-1 viral proteins, not only in isolation, but also in the context of full viral replication.
. 2011 Jun 6;8(Suppl 1):A125. doi: 10.1186/1742-4690-8-S1-A125
Tax-mediated re-routing of the HTLV-1 p13 protein to nuclear speckles
Vibeke Andresen
1, Cynthia A Pise-Masison
1, Uma Sinha-Datta
2, Robyn Washington Parks
1, Valentina Cecchinato
1, Risaku Fukumoto
1, Christophe Nicot
2, Genoveffa Franchini
1,✉
Vibeke Andresen
1Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, 20892, USA
Find articles by Vibeke Andresen
Cynthia A Pise-Masison
1Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, 20892, USA
Find articles by Cynthia A Pise-Masison
Uma Sinha-Datta
2Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, 66160, USA
Find articles by Uma Sinha-Datta
Robyn Washington Parks
1Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, 20892, USA
Find articles by Robyn Washington Parks
Valentina Cecchinato
1Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, 20892, USA
Find articles by Valentina Cecchinato
Risaku Fukumoto
1Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, 20892, USA
Find articles by Risaku Fukumoto
Christophe Nicot
2Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, 66160, USA
Find articles by Christophe Nicot
Genoveffa Franchini
1Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, 20892, USA
Find articles by Genoveffa Franchini
1Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, 20892, USA
2Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, 66160, USA
✉
Corresponding author.
Supplement
15th International Conference on Human Retroviruses: HTLV and Related VirusesAnne-Mieke Vandamme and Luc Willemshttp://www.biomedcentral.com/content/pdf/1742-4690-8-S1-info.pdf
Conference
5-8 June 2011
15th International Conference on Human Retroviruses: HTLV and Related Viruses
Leuven and Gembloux, Belgium
Collection date 2011.
Copyright ©2011 Andresen et al; licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC3112593
